Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence-Guided Lymphatic Mapping in Colon Cancer
NCT07638956Not yet recruiting
- Sponsor
- Tanta University
- Start
- Jun 2026
- Primary completion
- Sep 2027
01
Overview
Open-label, single-arm trial of indocyanine green in colon cancer, sponsored by Tanta University. Primary endpoint: Proportion of analyzable pN+ patients with all metastatic lymph nodes located within the ICG-mapped lymphatic basin at 2 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT07638956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07638956.